Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-Year follow-up of antibody concentrations

Vaccine

Volumn 18, Issue 5-6, 1999, Pages 524-530

  Kroon, Frank P ^a   Van Dissel, Jaap T ^a   Ravensbergen, Elisabeth ^a   Nibbering, Peter H ^a   Van Furth, Ralph ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD4+ T lymphocytes; HIV infection; Pneumococcal polysaccharide vaccine

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; DIDANOSINE; IMMUNOGLOBULIN G; LAMIVUDINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; T LYMPHOCYTE; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES; TIME FACTORS; VACCINATION;

EID: 0032845135     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00240-6     Document Type: Article

References (45)

1. Simberkoff M.S., El Sadr W., Schiffman G., Rahal J.J. Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a Pneumococcal vaccine failure. Am. Rev. Respir. Dis. 130:1984;1174-1176.
2. Rodriguez-Barradas M.C., Musher D.M., Hamill R.J., Dowell M., Bagwell J.T., Sanders C.V. Unusual manifestations of Pneumococcal infection in Human Immunodeficiency Virus-infected individuals: the past revisited. Clin. Infect. Dis. 14:1992;192-199.
3. Redd S.C., Rutherford G.W. III, Sande M.A., Lifson A.R., Hadley W.K., Facklam R.R., Spika J.S. The role of Human Immunodeficiency Virus infection in Pneumococcal bacteremia in San Fransisco residents. J. Infect. Dis. 162:1990;1012-1017.
4. García-Leoni M.E., Moreno S., Rodeñó P., Cercenado E., Vicente T., Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the Human Immunodeficiency Virus. Arch. Intern. Med. 152:1992;1808-1812.
5. Janoff E.N., Breiman R.F., Daley C.L., Hopewell P.C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspective. Ann. Intern. Med. 117:1992;314-324.
6. Gilks C.F., Ojoo S.A., Ojoo J.C., Brindle R.J., Paul J., Batchelor B.I.F., Kimari J.N., Newnham R., Bwayo J., Plummer F.A., Warrel D.A. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sexworkers in Nairobi, Kenya. Lancet. 347:1996;718-723.
7. Hirschtick R.E., Glassroth J., Jordan M.C., et al. Bacterial pneumoniae in persons infected with the Human Immunodeficiency Virus. N. Engl. J. Med. 333:1995;845-851.
8. Frankel R.E., Virata M., Hardalo C., Altice F.L., Friedland G. Invasive Pneumococcal Disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without Human Immunodeficiency Virus infection. Clin. Infect. Dis. 23:1996;577-584.
9. Centers for Disease Control, Prevention. Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb. Mortal. Wkly. Rep. 40:(RR-12):1991;1-94.
10. Guide for adult immunization. 2nd ed. 1990;American College of Physicians, Philadelphia.
11. Rose D.N., Schechter C.B., Sacks H.S. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am. J. Med. 94:1993;160-168.
12. Hirschtick R.E., Glassroth J., Jordan M.C. Bacterial pneumoniae in HIV. N. Engl. J. Med. 334:1996;195.
13. Jain A., Jain S., Gant V. Should patients positive for HIV receive pneumococcal vaccine? BMJ. 310:1995;1060-1062.
14. Mosier D.E., Subbarao B. Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunology Today. 3:1982;217-222.
15. + lymphocytes. AIDS. 8:1994;469-476.
16. Ballet J.J., Sulcebe G., Couderc L.J., et al. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin. Exp. Immunol. 68:1987;479-487.
17. Mascart-Lemone F., Gérard M., Libin M., Crusiaux A., Franchioly P., Lambrechts A., Goldman M., Clumeck N. Differential effect of Human Immunodeficiency Virus infection on the IgA and IgG antibody response to Pneumococcal vaccine. J. Infect. Dis. 172:1995;1253-1260.
18. Vandenbruaene M., Colebunders R., Mascart-Lemone F., Haerden Y., Van Hove D., Peeters M., Goeman J., Van Royen P., Avonts D. Equal IgG antibody response to Pneumococcal vaccination in all stages of Human Immunodeficiency Virus disease. J. Infect. Dis. 172:1995;551-553.
19. Huang K.L., Ruben F.L., Rinaldo C.R., Kingsley L., Lyter D.W., Ho M. Antibody responses after influenza and pneumococcal immunisation in HIV-infected homosexual men. JAMA. 257:1987;2047-2050.
20. Opravil M, Fierz W, Matter L, Blaser J, Luethy R, Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients, Clin. Exp. Immunol. 84:185-189.
21. Ragni M.V., Ruben F.L., Winkelstein A., Spero J.A., Bontempo F.A., Lewis J.H. Antibody responses to immunization of patients with hemophilia with and without evidence of Human Immunodeficiency Virus (human T-lymphotropic virus type III) infection. J. Lab. Clin. Med. 109:1987;545-549.
22. Klein R.S., Selwyn P.A., Maude D., Pollard C., Freeman K., Schiffman G. Response to Pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with Human Immunodeficiency Virus. J. Infect. Dis. 160:1989;826-831.
23. Rodriges-Barradas M.C., Musher D.M., Lahart C., et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of Human Immunodeficiency Virus-infected subjects with 23-valent Pneumococcal vaccine. J. Infect. Dis. 165:1992;553-556.
24. Bacterial meningitis in the Netherlands; Annual reports. The Netherlands Reference Laboratory for Bacterial Meningitis (RIVM/UvA) Amsterdam: University of Amsterdam, 1988, 1989, 1990, 1991.
25. Musher D.M., Groover J.E., Rowland J.M., Watson D.A., Struewing J.B., Baughn R.E., Mufson M.A. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin. Inf. Dis. 17:1993;66-73.
26. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal. Wkly. Rep. 41:1992;. (no. RR-17).
27. King J.C. Jr, Vink P.E., Chang I., et al. Antibody titers 8 months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than 2 years of age. Vaccine. 16:1998;361-365.
28. Go E.S., Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J. Allergy Clin. Immunol. 98:1996;205-214.
29. Ochs H.D., Junker A.K., Collier A.C., Virant F.S., Handsfield H.H., Wedgewood R.J. Abnormal antibody responses in patients with persistent lymphadenopathy. J. Clin. Immunol. 8:1988;57-63.
30. Janoff E.N., Douglas J.M., Gabriel M., et al. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with the Human Immunodeficiency Virus type 1. J. Infect. Dis. 158:1988;983-990.
31. Loeliger A.E., Rijkers G.T., Aerts P., Been-Tiktak A., Hoepelman A.I., van Dijk H., Borleffs J.C. Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients. FEMS Immunol. Med. Microbiol. 12:1995;33-41.
32. ™ in HIV infected patients. [abstract]. Proceedings of the VII International Conference on AIDS, June 16-21, Florence, Italy; 1991: WB 2275. 1991.
33. Unsworth D.J., Rowen D., Carne C., Sonnex C., Baglin T., Brown D.L. Defective IgG2 response to Pneumovax in HIV seropositive patients. Genitourin Med. 69:1993;373-376.
34. Anderson J., Coutinho A., Lernhart W., Melchers F. Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell. 10:1977;27-34.
35. Coutinho A. The theory of the one non-specific model for B-cell activation. Transplant Rev. 23:1975;49-65.
36. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the Acquired Immunodeficiency Syndrome. N. Engl. J. Med. 309:1983;453-458.
37. Pahwa S.G., Quilop M.T.J., Lange M., Pahwa R.N., Grieco M.H. Defective B-lymphocyte function in homosexual men in relation to the Acquired Immunodeficiency Syndrome. Ann. Intern. Med. 101:1984;757-763.
38. Ammann A.J., Schiffman G., Abrams D., Volberding P., Ziegler J., Conant M. B-cell immunodeficiency in the acquired immune deficiency syndrome. JAMA. 251:1984;1447-1449.
39. Mond J.J., Lees A., Snapper C.M. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:1995;655-692.
40. Lee C.J. Bacterial capsular polysaccharides: biochemistry, immunity and vaccine. Molecular Immunol. 24:1987;1005-1019.
41. Centers for Disease Control. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 46:(RR-8):1997;1-24.
42. Rodriguez-Barradas M.C., Groover J.E., Lacke C.E., Gump D.W., Lahart C.J., Pandey J.P., Musher D.M. IgG antibody to pneumococcal capsular polysaccharide in Human Immunodeficiency Virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J. Infect. Dis. 173:1996;1347-1353.
43. Weiss P.J., Wallace M.R., Oldfield E.C., O'Brien J., Janoff E.N. Response of recent Human Immunodeficiency Virus seroconverters to the Pneumococcal polysaccharide vaccine and Haemophilus influenzae Type B conjugate vaccine. J. Infect. Dis. 171:1995;1217-1222.
44. Li T.S., Tubiana R., Katlama C., Calvez V., Mohand H.A., Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet. 351:1998;1682-1686.
45. Kroon F.P., Rimmelzwaan G.F., Roos M.T.L., Osterhaus A.D.M.E., Hamann D., Miedema F., van Dissel J.T. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS. 12:1998;F217-F223.